Acquired von Willebrand syndrome and mitral valve prosthesis leakage. A pilot study

European Journal of Haematology

Volumn 87, Issue 5, 2011, Pages 448-456

  Pérez Rodríguez, Almudena ^a   Pinto, Joana Costa ^a   Lourés, Esther ^a   Rodríguez Trillo, Ángela ^a   Cuenca, José J ^b   Batlle, Javier ^a,c   López Fernández, María F ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Acquired von Willebrand syndrome; Bleeding diathesis; Mitral valve prosthesis; Surgery; Von Willebrand factor

Indexed keywords

ACENOCOUMAROL; BLOOD CLOTTING FACTOR 8; COLLAGEN BINDING PROTEIN; OXIDIZED REGENERATED CELLULOSE; PROTHROMBIN; VON WILLEBRAND FACTOR;

ACQUIRED VON WILLEBRAND SYNDROME; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLEEDING TENDENCY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPISTAXIS; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL PATIENT; HUMAN; MALE; MITRAL VALVE PROSTHESIS; MITRAL VALVE PROSTHESIS LEAKAGE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE STENOSIS; PARTIAL THROMBOPLASTIN TIME; PILOT STUDY; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHETIC VALVE THROMBOSIS; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CASE-CONTROL STUDIES; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; MITRAL VALVE; PILOT PROJECTS; VON WILLEBRAND DISEASES;

EID: 80054013902     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01664.x     Document Type: Article

References (35)

1. Veyradier A, Jenkins CS, Fressinaud E, Meyer D. Acquired von Willebrand syndrome: from pathophysiology to management. Thromb Haemost 2000;84:175-82.
2. Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE. Acquired von Willebrand Syndrome: data from an International Registry. Thromb Haemost 2000;84:345-9.
3. Sucker C, Michiels JJ, Zotz RB. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies. Acta Haematol 2009;121:177-82.
4. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987;69:454-9.
5. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993;123:893-8.
6. Kumar S, Pruthi RK, Nichols WL. Acquired von Willebrand's syndrome: a single institution experience. Am J Hematol 2003;72:243-7.
7. Federici AB. Acquired von Willebrand syndrome: is it an extremely rare disorder or do we see only the tip of the iceberg? J Thromb Haemost 2008;6:565-8.
8. Federici AB. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders. Semin Hematol 2006;43(1 Suppl 1):S48-58.
9. Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010;3:675-81.
10. Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010;56:1207-13.
11. Nitu-Whalley IC, Lee CA. Acquired von Willebrand syndrome-report of 10 cases and review of the literature. Haemophilia 1999;5:318-26.
12. Friederich PW, Wever PC, Briet E, Doorenbos CJ, Levi M. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease. Am J Hematol 2001;66:292-4.
13. Sucker C, Scharf RE, Zotz RB. Use of recombinant factor VIIa in inherited and acquired von Willebrand disease. Clin Appl Thromb Hemost 2009;15:27-31.
14. Batlle J, López Fernández MF. Laboratory assays for von Willebrand factor. In: Zimmerman TS, Ruggeri ZM, eds. Coagulation and Bleeding Disorders: the Role FVIII and von Willebrand factor. New York: Marcel Dekker, Inc, 1989:325-42.
15. Budde U, Schneppenheim R, Plendl H, Dent J, Ruggeri ZM, Zimmerman TS. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990;63:312-5.
16. Dent JA, Galbusera M, Ruggeri ZM. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 1991;88:774-82.
17. Castaman G, Lattuada A, Ruggeri M, Tosetto A, Mannucci PM, Rodeghiero F. Platelet von Willebrand factor abnormalities in myeloproliferative syndromes. Am J Hematol 1995;49:289-93.
18. O'Rourke DJ, Palac RT, Malenka DJ, Marrin CA, Arbuckle BE, Plehn JF. Outcome of mild periprosthetic regurgitation detected by intraoperative transesophageal echocardiography. J Am Coll Cardiol 2001;38:163-6.
19. Warkentin TE, Moore JC, Anand SS, Lonn EM, Morgan DG. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfus Med Rev 2003;17:272-86.
20. Ionescu A, Fraser AG, Butchart EG. Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transesophageal echocardiography. Heart 2003;89:1316-21.
21. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;49(4):343-9.
22. Anderson RP, McGrath K, Street A. Reversal of aortic stenosis bleeding gastrointestinal angiodysplasia and von Willebrand syndrome by aortic valve replacement. Lancet 1996;347:689-90.
23. Sadler JE. Aortic Stenosis, von Willebrand factor, and bleeding. N Engl J Med 2003;349:323-5.
24. Yoshida K, Tobe S, Kawata M, Yamaguchi M. Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis. Ann Thorac Surg 2006;81:490-4.
25. Yoshida K, Tobe S, Kawata M. Acquired von Willebrand disease type IIA in patients with aortic valve stenosis. Ann Thorac Surg 2006;81:1114-6.
26. Morishima A, Marui A, Shimamoto T, Saji Y, Tambara K, Nishina T, Komeda M. Successful aortic valve replacement for Heyde syndrome with confirmed hematologic recovery. Ann Thorac Surg 2007;83:287-8.
27. Zuppiroli A, Cecchi F, Ciaccheri M, Italiani G, Dolara A, Longo G, Matucci M, Morfini M, Rafanelli D. Platelet function and coagulation studies in patients with mitral valve prolapse. Clin Cardiol 1986;9:487-92.
28. Froom P, Margulis T, Grenadier E, Palant A, David M, Aghai E. Von Willebrand factor and mitral valve prolapse. Thromb Haemost 1988;60:230-1.
29. Goldsmith IR, Blann AD, Patel RL, Lip GY. Von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair. Am J Cardiol 2000;85:1218-22.
30. Goldsmith I, Kumar P, Carter P, Blann AD, Patel RL, Lip GY. Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study. Am Heart J 2000;140:777-84.
31. Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, Eisert R, Ganser A, Budde U. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost 2008;6:569-76.
32. Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, van de Velden A, Berneman Z. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3. Semin Thromb Hemost 2006;32:636-45. Review.
33. Pérez-Rodríguez A, García-Rivero A, Lourés E, López-Fernández MF, Rodríguez-Trillo A, Batlle J. Autosomal dominant C1149R von Willebrand disease: phenotypic findings and their implications. Haematologica 2009;94:679-86.
34. Tsai HM, Sussman II, Nagel RL. Shear stress enhances the proteolysis of von Willebrand factor in plasma normal. Blood 1994;83:2171-9.
35. Smaradottir A, Bona R. A case of acquired von Willebrand syndrome successfully treated with recombinant Factor VIIa during thyroidectomy. Thromb Haemost 2004;92:666-7.